An overview of Chagas Disease and Treatment.

Hdl Handle:
http://hdl.handle.net/10144/31335
Title:
An overview of Chagas Disease and Treatment.
Authors:
Jannin, J; Villa, L
Journal:
Memórias do Instituto Oswaldo Cruz
Abstract:
Chagas disease (American trypanosomiasis) is endemic in 21 countries of the Americas, where control is largely focused on elimination of the domestic insect vectors (Triatominae) coupled with measures to extend and improve the screening of blood donors in order to avoid tranfusional transmission. Through national programmes and multinational initiatives coordinated by WHO-PAHO, much has been accomplished in these domains in terms of reducing transmission. Attention now turns to consolidating the successes in interrupting transmission, and improved treatment for those already infected and those who may become affected in the future. This article, based on technical discussions at the "Epidemiological and Sociological Determinants of Chagas Disease, Basic Information to Establish a Surveillance and Control Policy " meeting in Rio de Janeiro, is designed to open the debate on appropriate strategies for continuation of the successful initiatives against Chagas disease.
Affiliation:
Innovative & Intensified Disease Management, Neglected Tropical Diseases, WHO, Geneva, Switzerland. janninj@who.int
Issue Date:
30-Oct-2007
URI:
http://hdl.handle.net/10144/31335
PubMed ID:
17906803
Language:
en
ISSN:
0074-0276
Appears in Collections:
Other Diseases

Full metadata record

DC FieldValue Language
dc.contributor.authorJannin, J-
dc.contributor.authorVilla, L-
dc.date.accessioned2008-07-08T15:25:54Z-
dc.date.available2008-07-08T15:25:54Z-
dc.date.issued2007-10-30-
dc.identifier.citationAn overview of Chagas disease treatment. 2007, 102 Suppl 1:95-7 Mem. Inst. Oswaldo Cruzen
dc.identifier.issn0074-0276-
dc.identifier.pmid17906803-
dc.identifier.urihttp://hdl.handle.net/10144/31335-
dc.description.abstractChagas disease (American trypanosomiasis) is endemic in 21 countries of the Americas, where control is largely focused on elimination of the domestic insect vectors (Triatominae) coupled with measures to extend and improve the screening of blood donors in order to avoid tranfusional transmission. Through national programmes and multinational initiatives coordinated by WHO-PAHO, much has been accomplished in these domains in terms of reducing transmission. Attention now turns to consolidating the successes in interrupting transmission, and improved treatment for those already infected and those who may become affected in the future. This article, based on technical discussions at the "Epidemiological and Sociological Determinants of Chagas Disease, Basic Information to Establish a Surveillance and Control Policy " meeting in Rio de Janeiro, is designed to open the debate on appropriate strategies for continuation of the successful initiatives against Chagas disease.en
dc.language.isoenen
dc.rightsArchived with thanks to Memórias do Instituto Oswaldo Cruzen
dc.subject.meshChagas Diseaseen
dc.subject.meshHealth Services Accessibilityen
dc.subject.meshHumansen
dc.subject.meshInternational Cooperationen
dc.subject.meshNifurtimoxen
dc.subject.meshNitroimidazolesen
dc.subject.meshPan American Health Organizationen
dc.subject.meshTrypanocidal Agentsen
dc.titleAn overview of Chagas Disease and Treatment.en
dc.contributor.departmentInnovative & Intensified Disease Management, Neglected Tropical Diseases, WHO, Geneva, Switzerland. janninj@who.inten
dc.identifier.journalMemórias do Instituto Oswaldo Cruzen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.